Dear Duke Pediatrics Colleagues,
The following are new and competitive renewal research awards made to investigators in the Duke Department of Pediatrics through the months of September and October 2025. These awards represent the successful culmination of work from numerous members of Duke Pediatrics covering exciting basic, translational, and clinical research. Please extend your congratulations to the following faculty members and their research teams.
Thank you,
Marsha Newby, Senior Grants and Contracts Manager
Christoph Hornik, MD PhD MPH, Vice Chair Research
|
|
|
| Bruno Chumpitazi, MD, MPH
Instructor Temporary in the Department of Pediatrics, Gastroenterology
Phase 3 Study to Assess the Safety and Efficacy of Tenapanor
Ardelyx, Inc.
09/07/2025-10/01/2027
|
|
|
Rasheed Gbadegesin, MBBS
Wilburt C. Davison Distinguished Professor Professor of Pediatrics, Nephrology
Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants with APOL1-Mediated Kidney Disease (APPRECIATE)
AstraZeneca AB
09/17/2025-12/17/2029
|
|
|
|
| Rebecca Koch, PhD
Assistant Professor of Pediatrics, Medical Genetics
Assessment of GYS1 Knockdown on Pompe Disease
Alnylam U.S., Inc.
09/06/2025-09/30/2026
|
|
|
Andrew Landstrom, MD, PhD
Professor of Pediatrics, Cardiology
Jennifer Li, MD
Beverly C. Morgan, M.D., Distinguished Professor of Pediatric of Pediatrics, Cariology
T32 Institutional Training Grant
iPediHeart: Interdisciplinary Research Training Program for Pediatric Heart Disease
National Institutes of Health/ NHLBI
09/01/2025-08/31/2030
|
| |
|
|
| Brian Smith, MD, MHS, MPH
Samuel L. Katz Distinguished Professor of Pediatrics Professor of Pediatrics, Neonatology
U2C Supplemental Award
ECHO Coordinating Center- Kitting Expanded Scope
National Institute of Health
08/01/2025-05/31/2026
|
|
|
Jessica Sun, MD, PhD
Associate Professor of Pediatrics, Hematology-Oncology
SOG Trial S1826 - Children’s Oncology Group Foundation/Hope Foundation for Cancer Research (07/01/2025-06/30/2026)
AALL1732 - Public Health Institute/Servier Pharmaceuticals LLC (03/17/2025-06/16/2028)
|
|
|
|
| Muhammad Zafar, MBBS
Associate Professor of Pediatrics, Neurology
Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Therapy in Patients with Lennox-Gastaut
Epygenix Therapeutics Inc.
09/23/2025-07/03/2028
|
|
|
Sarah Armstrong, MD
Professor of Pediatrics, General Pediatrics and Adolescent Health
Are Interventions Supporting Physical Activity Modified by the Environment (InSpace)
Seattle Children’s Research Institute/National Institutes of Health
07/01/2025-04/30/2026
|
|
|
|
| Michael Jay Campbell, MD
Professor of Pediatrics, Cardiology
Outcome Measures for DMD Drug Trials Fixed Rate
Vanderbilt University Medical Center/National Institutes of Health
09/01/2025-06/30/2030
|
|
|
Rasheed Gbadegesin, MBBS
Wilburt C. Davison Distinguished Professor Professor of Pediatrics, Nephrology
APOL1-Associated Nephropathy from Human-Derived, Intrarenal Perspective
Boston Children’s Hospital/National Institutes of Health
09/01/2025-06/30/2030
|
|
|
|
| Natalie Katz, MD
Assistant Professor of Pediatrics, Neurology
A Long-term Multicenter Prospective Observational Study Evaluating the Comparative Effectiveness and Safety of Sarepta Gene Transfer Therapy vs. Standard of Care in Participants with Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc.
10/01/2025-12/31/2035
|
|
|
Priya Kishnani, MBBS
Chen Family Distinguished Professor of Pediatrics, Medical Genetics
Pompe Case Report
Amicus Therapeutics, Inc.
10/16/2025-08/31/2026
|
|
|
|
|
| Andrew Landstrom, MD, PhD
Professor of Pediatrics, Cardiology
IPRISM (Imaging-Enhanced Prediction of Risk for Sudden Cardiac Death in HcM
Oregon Health and Science University/National Institutes of Health
07/01/2025-06/30/2029
|
|
|
Kris Mahadeo, MD
Professor of Pediatrics, Transplant and Cellular Therapy
Phase 1/2 Open-Label, Single-Ascending-Dose Study of EN-374, a Helper-Dependent Adenoviral-Based Gene Therapy, in Participants with X-Linked Chronic Granulomatous Disease - Ensoma Inc. (09/16/2025-12/31/2027)
JMML Allogeneic Hematopoietic Cell Transplantation - University of California-San Francisco (01/01/2025-12/31/2025)
|
|
|
|
| Niraj Patel, MD
Associate Professor of Pediatrics, Allergy and Immunology
A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety of Kedrion
Kedrion S.p.A.
10/10/2025-04/05/2027
|
|
|
Jessica Sun, MD, PhD
Associate Professor of Pediatrics, Hematology-Oncology
AR66913: PEPN1924 Leidos Site Correlative Services
Public Health Institute/Leidos Biomedical Research, Inc.
08/31/2021-08/30/2025
|
|
|
|
| Emmanuel Walter, MD, MPH
Professor of Pediatrics, Infectious Diseases
CIVICs C Option 8B Phase 1 Equitable Adjustment (EA)
National Institutes of Health
02/22/2021-09/15/2026
|
|
|
Charles Wood, MD, MPH
Associate Professor of Pediatrics, General Pediatrics and Adolescent Health
Evaluating EHR-based Prediction of Obesity using WHO Weight Velocity Standards and Peak BMI
Cincinnati Children’s Hospital
09/01/2025-08/31/2027
|
|
|
|
Questions or feedback on this newsletter or its contents, please contact:
PediatricResearch@duke.edu
Duke Department of Pediatrics
pediatrics.duke.edu/research
|
| |
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
2400 Pratt Street | Durham, NC 27710 US
|
|
|
This email was sent to pediatricresearch@dm.duke.edu.
To continue receiving our emails, add us to your address book.
|
|
|
|